Phase III randomized study of second line ADI-peg 20 (A) plus best supportive care versus placebo (P) plus best supportive care in patients (pts) with advanced hepatocellular carcinoma (HCC) Meeting Abstract
| Authors: | Abou-Alfa, G. K.; Qin, S.; Ryoo, B. Y.; Lu, S. N.; Yen, C. J.; Feng, Y. H.; Lim, H. Y.; Izzo, F.; Colombo, M.; Sarker, D.; Bolondi, L.; Vaccaro, G. M.; Harris, W. P.; Chen, Z.; Hubner, R.; Meyer, T.; Bomalaski, J. S.; Lin, C. C.; Chao, Y.; Chen, L. T. |
| Abstract Title: | Phase III randomized study of second line ADI-peg 20 (A) plus best supportive care versus placebo (P) plus best supportive care in patients (pts) with advanced hepatocellular carcinoma (HCC) |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 210s |
| Language: | English |
| ACCESSION: | WOS:000404665405243 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.4017 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4017 -- Source: Wos |
